Product Images Trulicity
View Photos of Packaging, Labels & Appearance
- Label Image - lbl500903483
- Label Image - lbl500903484
- Logo - logo
- QR Code - qr v1
- Figure - trulicity ifu 0point75 injection sites v1
- Figure - trulicity ifu 1point5 injection sites v1
- Figure - trulicity ifu 3mg injection sites v1
- Figure - trulicity ifu 4point5mg injection sites v1
- Figure - trulicity ifu check v1
- Exclamation - trulicity ifu exclamation v1
- Figure - trulicity ifu expiration location v2
- Figure - trulicity ifu inspect v1
- Locked - trulicity ifu locked v1
- Figure - trulicity ifu prepare v1
- Figure - trulicity ifu remove v1
- Figure - trulicity ifu sup 0point75 f2 v3
- Figure - trulicity ifu sup 0point75 f3 v3
- Figure - trulicity ifu sup 0point75 f4 v3
- Figure - trulicity ifu sup 0point75 f5 v3
- Figure - trulicity ifu sup 0point75 pen parts v3
- Figure - trulicity ifu sup 0point75 pen v3
- Figure - trulicity ifu sup 1point5 f2 v3
- Figure - trulicity ifu sup 1point5 f3 v3
- Figure - trulicity ifu sup 1point5 f4 v3
- Figure - trulicity ifu sup 1point5 f5 v3
- Figure - trulicity ifu sup 1point5 pen parts v3
- Figure - trulicity ifu sup 1point5 pen v3
- Figure - trulicity ifu sup 3mg f2 v1
- Figure - trulicity ifu sup 3mg f3 v1
- Figure - trulicity ifu sup 3mg f4 v1
- Figure - trulicity ifu sup 3mg f5 v1
- Figure - trulicity ifu sup 3mg pen parts v1
- Figure - trulicity ifu sup 3mg pen v1
- Figure - trulicity ifu sup 4point5 f2 v1
- Figure - trulicity ifu sup 4point5 f3 v1
- Figure - trulicity ifu sup 4point5 f4 v1
- Figure - trulicity ifu sup 4point5 f5 v1
- Figure - trulicity ifu sup 4point5 pen parts v1
- Figure - trulicity ifu sup 4point5 pen v1
- Figure - trulicity ifu unfold v1
- Unlocked - trulicity ifu unlock v1
- Figure 1 - trulicity pi f1 v2
- Figure 2 - trulicity pi f2 v2
- Figure 3 - trulicity pi f3 v1
- Figure 5 - trulicity pi f4 v1
- Figure 6 - trulicity pi f5 v1
- Figure 4 - trulicity pi f6 v1
Product Label Images
The following 47 images provide visual information about the product associated with Trulicity NDC 50090-3483 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - trulicity ifu sup 0point75 pen parts v3

The text appears to be describing the different parts of a medical injection device. It includes labels for a "Top," "Button," "LockRing," "Indicator," "Medicine," "Bottom," "Needle," "End," and "Base Cap." The text seems to be explaining how to use the device, but without additional context or images, it is difficult to provide more specific information.*
Figure - trulicity ifu sup 1point5 pen parts v3

The text is describing the parts of an injection pen. It includes labels for the top and bottom pieces, a lock ring and indicator, and a button to dispense the medicine. There is also a needle and end cap mentioned.*
Figure - trulicity ifu sup 3mg f4 v1

This is a simple instruction about administering an injection. Once the gray plunger is visible, it signals the completion of the injection.*
Figure - trulicity ifu sup 3mg pen parts v1

The text seems to be a partial description of a device or product. It mentions a "Top B MR injection Button" and a "LockRing" with an indicator for locking and unlocking. Additionally, there is a mention of "Medicine", which possibly indicates that the product may be used in the medical field. However, the context and purpose of the device cannot be determined with this limited information.*
Figure - trulicity ifu sup 4point5 f4 v1

This text provides instructions for administering an injection. Specifically, it indicates that the injection process is complete when the gray plunger is visible. The text does not provide any further information concerning the type of injection or its purpose.*
Figure 4 - trulicity pi f6 v1

This is a description of the Trulicity medication, available in dosages of 1.5mg, 3mg, and 45mg, with observed mean HbATc at scheduled visits and a retrieved dropout multiple imputation (MI) based estimate at week 36. The chart shows the number of subjects with observed data at different weeks post-randomization for each dosage.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.